Interview with Dr. Christian Reinhard at UEGW 2016 about the first 18 months of market experience with IBDoc®
At this year’s UEGW in Vienna, Dr. Christian Reinhard presented data collected from the first 18 months of market experience with IBDoc®. In the biomarker session on Tuesday 18th of October the IBDoc® product manager at BÜHLMANN Laboratories AG
presented an overview of the published data and including some new and unpublished data from a study with 58 patients. The study was focused on a comparison of the new calprotectin home test with the laboratory gold standard BÜHLMANN fCAL® ELISA. In this method comparison a total within target agreement of 80% was reached. After the oral presentation we recorded an interview covering the most recent data and the outlook for calprotectin home testing.
Have a look at the orignial YouTube Video on the BÜHLMANN YouTube channel.